Raloxifene: FDA approved treatment for decreasing fracture risk in osteoporosis

Raloxifene is a U.S. Food and Drug Administration (FDA)-approved treatment for decreasing fracture risk in osteoporosis. While raloxifene is as effective at reducing fracture risk as other current treatments, this works only partially by suppressing bone loss. With the use of wide- and…

Raloxifene: FDA approved treatment for decreasing fracture risk in osteoporosis